Meeting
2013 ASCO Annual Meeting
Comparison of HER2 expression in paired biopsies and surgical specimen of gastric and esophageal adenocarcinoma: Impact of neoadjuvant chemotherapy.
Authors
Sarah Watson
Department of Oncology, Institut Mutualiste Montsouris, Paris, France
Sarah Watson , Pierre Validire , Pascale Cervera , Nabila Zorkani , Frederic Lemay , Thierry Perniceni , Francois Paye , Christophe Tournigand , Christophe Louvet
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 31, 2013 (suppl; abstr 4069)
DOI
10.1200/jco.2013.31.15_suppl.4069
Abstract #
4069
Poster Bd #
19G
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Invasive disease free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab.
First Author: Sonya Chew
Poster
2022 ASCO Annual Meeting
![The HERPET study: Imaging HER2 expression in breast cancer with the novel PET tracer [<sup>18</sup>F]GE-226, a first-in-patient study.](https://d201v5jt9ylckg.cloudfront.net/288/14358/211270/211270_A4766_poster_pv.jpg)
The HERPET study: Imaging HER2 expression in breast cancer with the novel PET tracer [18F]GE-226, a first-in-patient study.
First Author: Laura M. Kenny
Poster
2018 ASCO Annual Meeting
Frequency of overexpression of HER3 and prognostic consequences in European patients with early gastric cancer.
First Author: Nieves Martinez Lago
Poster
2013 Gastrointestinal Cancers Symposium
Comparison of HER-2 expression in diagnostic biopsies and surgical specimens of gastric and esophageal adenocarcinoma: Influence of neoadjuvant chemotherapy.
First Author: Sarah Watson